Purpose To develop evidence-based clinical practice recommendations regarding
transfusion practices and transfusion in bleeding critically ill adults. Methods A taskforce …

Background: Recent studies have highlighted the unfavorable prognosis of patients with
spontaneous intracerebral hemorrhage (ICH) who have received prior antiplatelet therapy …

The evidence suggests that antiplatelet agents (APA) slightly increase the risk of death and
disease progression in patients with traumatic brain injury or spontaneous intracranial …

There is an increasing prevalence of cardiovascular diseases that warrant antithrombotic
therapy. Antithrombotic therapy includes antiplatelet agents and anticoagulation therapy …

Background We examined platelet transfusion (PTx) in the Ethnic/Racial Variations of
Intracerebral Hemorrhage (ERICH) study, hypothesizing that rates of PTx would vary among …

Introduction The practice of platelet transfusion to mitigate the deleterious effects of
antiplatelet agents on spontaneous intracerebral hemorrhage (ICH) remains common …

Background Hematoma expansion (HE) is the leading cause of early neurological
deterioration, poor functional outcome, and increased mortality in patients with spontaneous …

Background An increasing number of patients with intracranial haemorrhages are aspirin-
users. Neurosurgeons commonly attempt to minimize the risk of re-bleeding by withholding …

Objective Frameless stereotactic aspiration of a hematoma can be the one of the treatment
options for spontaneous intracerebral hemorrhage in the basal ganglia. Postoperative …

1. Heidenreich F, Leifeld L, Jovin T. T cell-dependent activity of ganglioside GM1-specific B
cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro. J Neuroimmunol …